The presence of left ventricular hypertrophy (LVH) usuavoided. In hypertensive patients with congestive heart ally indicates that hypertension is moderately severe failure, amlodipine should be added to triple therapy and that combination therapy will be required to control with an ACE inhibitor, whereas in the post myocardial blood pressure (BP). Unfortunately, most studies on the ischemia patient, verapamil may exert some additional reduction of LVH have been done with monotherapy.
Introduction
death and other cardiovascular events increases sixThe most common manifestation of hypertensive to eight-fold with the occurrence of LVH. 2-5 Once heart disease is left ventricular hypertrophy (LVH) LVH is present by electrocardiographic and echocar- (Figure 1 ), arbitrarily defined as an increase in left diographic criteria, hypertension is usually moderventricular mass exceeding certain established criately severe and blood pressure (BP) rarely will be teria. 1 LVH cannot simply be considered as a comcontrolled by monotherapy. Thus, in the patient pensatory mechanism. The Framingham Heart with LVH, two or more drugs are often used to Study has documented that the risk of acute myocarachieve normotension. Unfortunately, most studies regarding target organ damage in hypertension were carried out by focusing on the effects of monotherapy. These extrapolations, however provocative and suggestive clinically, may not always prove to be beneficial in terms of morbidity and mortality.
Combination therapy: general principles
Because of multiple mechanisms that are involved in the pathogenesis of essential hypertension, a single drug class may not address all of them; in fact, monotherapy sufficiently controls BP in only 50-60% instances. 6 Efficacy of a drug is often lowered due to the stimulation of compensatory mechanisms. Combination therapy allows the use of lower doses of each antihypertensive agent; therefore, excess stimulation may be avoided, and, conceivably, the second component of combination may counteract this stimulation. It is not yet clear showed at most an additive effect of antihypertensive therapy regardless of which combination of drug classes was used. 9 The use of lower doses of 13 performed a meta-analysis that only considered randomized studies coma diuretic should, therefore, probably not be used in an asymptomatic patient with LVH. Such a combiparing the effects of two or more therapies by assessing LVH and structure with blindly read echonation may also synergistically elicit hypokalemia which could aggravate or trigger ventricular arrhythcardiograms. Out of more than 400 applications, only 39 clinical trials fulfilled these criteria. Similar mias. to previous meta-analyses, the decrease in left ventricular mass was greater with active drug treatment than with placebo, and was directly related to the Systolic dysfunction -congestive heart pretreatment left ventricular mass, control of pressure and duration of treatment. When the analysis failure was adjusted for the study duration, ACE inhibitors were most efficient in reducing LVH followed by As hypertensive cardiovascular disease progresses, the hypertrophied heart is no longer able to compencalcium channel blockers, the diuretics and the beta blockers.
13 Indeed, some reports suggest that ACE sate for an ever-increasing afterload. The left chamber becomes dilated, and a decrease in ejection inhibitors may lower BP more than one would expect from their unloading properties alone. The fraction and cardiac output can be observed. 20 Congestive heart failure is known to be a common comability of ACE inhibitors at a dose that does not lower BP to produce regression in LVH supports the plication of untreated longstanding hypertension. 21 Clearly, therefore, in the patient with systolic dyshypothesis that the local cardiac angiotensin system is a significant determinant of heart structure and function, drugs that exert negative inotropic effects, such as some calcium antagonists and beta-blockers, function.
14,15 As a class, calcium antagonists seem slightly less potent in reducing LVH than the ACE should be used with restraint. It must be remembered, however, that low doses of beta-blockers have inhibitors with heart rate lowering agents possibly having a greater effect than the dihydropyridines. A been shown to be beneficial, particularly in patients suffering from congestive heart failure as a result of lesser effect is assigned to the beta-blockers, the postsynaptic alpha-blockers and the diuretics. Of dilated cardiomyopathy. Similarly, it has recently been documented that the new compound carvedinote, however, recent findings in 690 men from the VA cooperative study showed hydrochlorothiazide lol improves morbidity and mortality in patients with congestive heart failure. 22 to be more efficacious than atenolol, captopril, diltiazem, prazosin or clonidine in reducing LVH. 16 It ACE inhibitors remain a cornerstone in the management of congestive heart failure and have been must be emphasized, however, that with a few exceptions [17] [18] [19] there are no prospective, ranclearly shown to be of benefit early as well as late in the evolution of the disease. The standard therapy domized, controlled trials comparing the effects of various antihypertensive drugs on left ventricular of congestive heart failure consists therefore of a diuretic, digitalis, and an ACE inhibitor. Two of mass. Also, there is uncertainty as to what a druginduced reduction of LVH exactly means in terms these drug classes are also commonly used to treat hypertension. In the PRAISE study, 23 patients with of morbidity and mortality.
There are no conclusive data that a reduction in congestive heart failure from dilated cardiomyopathy benefited from the addition of amlodipine. A LVH would confer a benefit that exceeded the one conferred by the reduction in arterial pressure per reasonable combination to be used in such patients who are concomitantly suffering from hypertension se. These drawbacks notwithstanding, it can be extrapolated that the combination of an ACE inhibiwould, therefore, be a diuretic, digitalis, an ACE inhibitor, and either amlodipine or perhaps carveditor with a calcium blocker ought to be particularly efficacious with regard to a reduction of LVH (Table  lol . Unlike amlodipine, which had no effect in patients with congestive heart failure caused by 1). Because both of these drug classes have the potential to interfere with pathogenesis of LVH at a ischemic cardiomyopathy, carvedilol had equal benefits in patients with both dilated cardiomyopasimilar level, one can argue that this combination will reduce LVH more than one would expect from thy and ischemic cardiomyopathy. no some yes ACE = angiotensin-converting enzyme; DHP = dihydropyridine; HRL = heart-rate-lowering; ↑ = increase; ↓ = decrease.
to the development of coronary atherosclerosis,
Impaired left ventricular filling and
exaggerated reactivity of cardiac arterioles, hypertrophic obstructive cardiomyopathy increased hemodynamic burden of the heart and Impairment in left ventricular filling has been docuincrease in left ventricular mass. The two drug mented as an early finding in hypertensive heart disclasses most commonly used to treat coronary artery ease. [24] [25] [26] However, most often this impairment is disease are the calcium antagonists and the betaasymptomatic and does not necessitate specific therblockers. It seems logical, therefore, to use a combiapy. In the occasional patient who is suffering from nation of these two drug classes in hypertensive dyspnea on exertion secondary to impaired filling, patients who are suffering from coronary artery disthe addition of either a calcium antagonist or a betaease and require two or more drugs for lowering of blocker to the current antihypertensive regimen arterial pressure. Indeed, fixed combinations of should be sufficient. When given for a prolonged some dihydropyridine calcium antagonists and betaperiod of time, ACE inhibitors have been shown to blockers have been marketed outside the US 30,31 but improve left ventricular filling inconsistently. 27 In only for hypertension and not for coronary artery contrast to the findings with calcium antagonists disease. By and large, the combination of a heart rate and beta-blockers which also have a direct effect on lowering calcium antagonist (verapamil, diltiazem) the early rapid filling phase, the effect by the ACE with a beta-blocker should be avoided because the inhibitors seems to be solely mediated by their two molecules could exert synergistic negative potential to improve ventricular compliance secondchronotropic and negative inotropic effects. ary to a reduction in left ventricular wall thickness.
The most commonly used drugs to treat hyper-
The post MI patient trophic obstructive cardiomyopathy (HCOM) are the calcium antagonists and the beta-blockers. Both of Multiple studies have shown that beta-blockers reduce the reinfarction rate and mortality after myothese drug classes are commonly used in the treatment of hypertension and, therefore, can be comcardial infarction (MI). 32 Similarly, ACE inhibitors have been shown to be beneficial in that they prebined in a patient concomitantly suffering from HCOM and hypertension. Of note, heart rate lowervent remodeling (and thereby reduce the long-term risk of congestive heart failure) and reduce reinfarcing calcium antagonists may have a greater benefit than the dihydropyridines because the former protion rates and even sudden death. 33 In contrast to beta-blockers and ACE inhibitors, the role of callong diastole and allow better left ventricular filling. HCOM may, therefore, be an indication for the comcium antagonists in the post MI patient is less well established. In the DAVIT II study, verapamil sigbination of a heart rate lowering calcium antagonist with a beta-blocker. This combination requires carenificantly reduced reinfarction rates when treatment began 1 to 2 weeks after the acute event. 34 Similarly, ful electrocardiographic monitoring since it may lead to an AV block or unmask sick sinus syndrome.
in the MDPIT study, diltiazem was shown to have some benefits in the patient with a non-Q wave infarction. 35 The effects of both verapamil and diltia-
Coronary artery disease
zem were more pronounced in patients with hypertension 36 and in patients without congestive heart Myocardial ischemia has been shown to be common among hypertensive patients. 28, 29 been shown to diminish the ventricular arrhyth-
